This promotional website is created by Autolus Theraputics and is intended for UK healthcare professionals with an interest in oncology

Prescribing Information

Adverse Event Reporting

Next-gen CAR T
Clinical data
Patient Eligibility
Process & Administration
Support and Resources
Treatment Centers

Next-gen CAR T
Clinical data
Patient Eligibility
Process & Administration
Support and Resources
Treatment Centers

Sitemap

Home
Next-gen CAR T
Clinical data
Patient Eligibility
Process & Administration
Support and Resources
Treatment Centers
Sitemap
Contact us
Cookie policy
Terms of use

April 2026 | UK-AUC-0184

Home
Contact us
Cookie policy
Sitemap
Terms of use

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

April 2026 | UK-AUC-0184

You are now leaving this website and will be redirected away from the current website. Do you wish to continue?

Yes

This site contains promotional information and is intended for UK healthcare professionals only.

Important notice: This site is intended for UK healthcare professionals. By entering this site, you are confirming that you are a UK healthcare professional.

This site is intended for members of the UK public. You will be redirected to the Autolus corporate website with Autolus contact information.

This site is intended for patients in the UK who have been prescribed AUCATZYL. You will be redirected to the Patient Information Leaflet on the emc website.

April 2026 | UK-AUC-0176

Yes

Continue